NLRP3 and autoimmune myocarditis: In recent studies, miR-223-3p has been identified to ameliorate experimental autoimmune myocarditis and inflammatory damage in retinal pigment epithelium by targeting NLRP3 (Hu et al., 2019; Chen et al., 2020).